RT Journal Article
SR Electronic
T1 AI-Driven Longitudinal Characterization of Neonatal Health and Morbidity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.31.22273233
DO 10.1101/2022.03.31.22273233
A1 De Francesco, Davide
A1 Reiss, Jonathan D.
A1 Roger, Jacquelyn
A1 Tang, Alice S.
A1 Chang, Alan L.
A1 Becker, Martin
A1 Phongpreecha, Thanaphong
A1 Espinosa, Camilo
A1 Morin, Susanna
A1 Berson, Eloïse
A1 Thuraiappah, Melan
A1 Le, Brian L.
A1 Ravindra, Neal G.
A1 Payrovnaziri, Seyedeh Neelufar
A1 Mataraso, Samson
A1 Kim, Yeasul
A1 Xue, Lei
A1 Rosenstein, Melissa
A1 Oskotsky, Tomiko
A1 Marić, Ivana
A1 Gaudilliere, Brice
A1 Carvalho, Brendan
A1 Bateman, Brian T.
A1 Angst, Martin S.
A1 Prince, Lawrence S.
A1 Blumenfeld, Yair J.
A1 Benitz, William E
A1 Fuerch, Janene H.
A1 Shaw, Gary M.
A1 Sylvester, Karl G.
A1 Stevenson, David K.
A1 Sirota, Marina
A1 Aghaeepour, Nima
YR 2022
UL http://medrxiv.org/content/early/2022/04/05/2022.03.31.22273233.abstract
AB While prematurity is the single largest cause of death in children under 5 years of age, the current definition of prematurity, based on gestational age, lacks the precision needed for guiding care decisions. Here we propose a longitudinal risk assessment for adverse neonatal outcomes in newborns based on a multi-task deep learning model that uses electronic health records (EHRs) to predict a wide range of outcomes over a period starting shortly after the time of conception and ending months after birth. By linking the EHRs of the Lucile Packard Children’s Hospital and the Stanford Healthcare Adult Hospital, we developed a cohort of 22,104 mother-newborn dyads delivered between 2014 and 2018. This enabled a unique linkage between long-term maternal information and newborn outcomes. Maternal and newborn EHRs were extracted and used to train a multi-input multi-task deep learning model, featuring a long short-term memory neural network, to predict 24 different neonatal outcomes. An additional set of 10,250 mother-newborn dyads delivered at the same Stanford Hospitals from 2019 to September 2020 was used to independently validate the model, followed by a separate analysis of 12,256 mothers-newborn dyads at the University of California, San Francisco. Moreover, comprehensive association analysis identified multiple known and new associations between various maternal and neonatal features and specific neonatal outcomes. To date, this is the largest study utilizing linked EHRs from mother-newborn dyads and would serve as an important resource for the investigation and prediction of neonatal outcomes. An interactive website is available for independent investigators to leverage this unique dataset: https://maternal-child-health-associations.shinyapps.io/shiny_app/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the NIH (1R01HL139844, 3P30AG066515, R35GM138353, 1R61NS114926, 1R01AG058417, R01HD105256, P01HD106414, T32GM007618, T32GM067547), Burroughs Welcome Fund (1019816), American Heart Association (19PABHI34580007), the March of Dimes, and the Robertson foundation. This research used data or services provided by STARR, “Stanford medicine Research data Repository,” a clinical data warehouse containing live Epic data from Stanford Health Care, the Stanford Children's Hospital, the University Healthcare Alliance and Packard Children's Health Alliance clinics and other auxiliary data from Hospital applications such as radiology PACS. STARR platform is developed and operated by Stanford Medicine Research IT team and is made possible by Stanford School of Medicine Research Office. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. 2038436. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Boards of Stanford University (#39225) and University of California, San Francisco (#17-22929)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe aggregated results set, that does not include patient-level health information, is available upon reasonable request to the authors. Data partners (Stanford University and University of California, San Francisco) contributing to this study remain custodians of individual patient-level health information.